4//SEC Filing
T2 Biosystems, Inc. 4
Accession 0001104659-17-028860
CIK 0001492674operating
Filed
May 1, 8:00 PM ET
Accepted
May 2, 3:54 PM ET
Size
5.3 KB
Accession
0001104659-17-028860
Insider Transaction Report
Form 4
DEPTULA-HICKS DARLENE M
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-05-01+175,000→ 175,000 totalExercise: $4.74Exp: 2027-05-01→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]25% of the total shares vest on 05/01/2018, and the remaining shares vest in substantially equal monthly installments over the following 36 months, to be fully vested on 05/01/2021.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001492674
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 3:54 PM ET
- Size
- 5.3 KB